Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer
about
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeElectronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome)Identification of rare germline copy number variations over-represented in five human cancer types.Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative.Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.Recurrent and founder mutations in the PMS2 gene.Deficient mismatch repair system in patients with sporadic advanced colorectal cancerImprovement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.Germline copy number variations and cancer predisposition.Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch SyndromeHeritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors
P2860
Q24655053-4FFF6C60-A516-46C5-8828-0B1FC5EA3095Q33892091-7044E3F9-45F5-4750-B02A-4FF04174D19EQ34325613-40A2510C-A820-4307-94CB-9BC77FB9C92CQ34351784-70F86B07-79CC-45EA-B005-64111CF46775Q35238058-03C0B904-948A-4FB8-BF67-B8839916B29BQ36001501-3FB71EF2-5BD7-46EA-9E72-08C6FB85EEACQ36051960-2C18C760-69E2-4813-940B-D71438B7BC51Q36098562-D1393418-EC65-4563-84AE-DD84E726491AQ36243503-BBC6F2AC-1A7B-4B21-91CE-2A6C320F49CCQ37081098-DD64B9F7-1BB7-4E88-86BC-A39CADF28589Q37407195-492C9E72-927A-481F-BD41-FBE254BCE282Q38003668-F3EC4FBA-AD18-48E7-8FDB-DB573061DBD9Q42039194-C6F9EE65-7924-4D74-97F3-21598F94D6A6Q42607034-2A615D2E-8BAF-46D4-8A4B-9F3742D75E50Q47155477-191175B9-B63A-45FC-96FB-2F7A4494FECCQ48615237-95ACF4AC-75E4-4CDF-BB53-7EC4428D196BQ57655214-5E2EE694-815E-4A5F-9664-895CBB32EEBD
P2860
Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Patients with an unexplained m ...... a low risk of familial cancer
@ast
Patients with an unexplained m ...... a low risk of familial cancer
@en
type
label
Patients with an unexplained m ...... a low risk of familial cancer
@ast
Patients with an unexplained m ...... a low risk of familial cancer
@en
prefLabel
Patients with an unexplained m ...... a low risk of familial cancer
@ast
Patients with an unexplained m ...... a low risk of familial cancer
@en
P2093
P2860
P356
P1476
Patients with an unexplained m ...... a low risk of familial cancer
@en
P2093
E van der Looij
H G Brunner
J H J M van Krieken
K M Hebeda
L I H Overbeek
M Goossens
M J L Ligtenberg
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603754
P407
P577
2007-04-24T00:00:00Z
P5875
P6179
1021822485